This module was delivered entirely in Spanish.
La Sociedad Dominicana de Endocrinología Pediátrica SODEP en conjunto con la Sociedad Dominicana de Endocrinología y Nutrición SODENN y el Children’s Hospital of Philadelphia CHOP, tienen el placer de invitarlos a mirar la charla “Hiperinsulinismo Congénito, Avances en el Diagnóstico y Tratamiento.”
Contamos con la participación de la Doctora Diva De León-Crutchlow, MD, MSCE. Jefe de la División de Endocrinología y Diabetes, Director del Centro de Hiperinsulinismo Congénito del Hospital de Niños de Filadelfia (CHOP).
Como moderadores tenemos el apoyo local de los doctores Alicia Troncoso Leroux y Elbi Morla Báez. Doctora Alicia Troncoso Leroux Médico endocrinólogo, Presidente de la Sociedad Dominicana de Endocrinología y Nutrición, SODENN. Doctor Elbi Morla Báez Pediatra endocrinólogo, maestro de la medicina y pediatra de la RD.
The Dominican Society of Pediatric Endocrinology (SODEP), in conjunction with the Dominican Society of Endocrinology and Nutrition (SODENN) and Children’s Hospital of Philadelphia (CHOP) are pleased to invite you to view a talk on Advances in Diagnosis and Treatment of Congenital Hyperinsulinism.
Our main speaker is Diva de León-Crutchlow, MD, MSCE, Chief of the Division of Endocrinology and Diabetes and Director of the Congenital Hyperinsulinism Center at CHOP.
Our moderators include local physicians Alicia Troncoso Leroux and Elbi Morla Báez. Dr. Alicia Troncoso Leroux is an endocrinologist and is President of the Dominican Society of Endocrinology and Nutrition (SODENN). Dr. Elbi Morla Báez is a pediatric endocrinologist, professor of medicine and pediatrician at the DR.
This seminar focuses on neurology and was delivered at a virtual event titled, Hiperinsulinismo Congénito, Avances en el Diagnóstico y Tratamiento, on May 20, 2021.
Additional CHOP Resources:
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.